Number of Shares
2,825.00
Current Holdings Value*
$350,000.00
% of Portfolio
0.04%
Total Estimate Gain
$-295,568.85
% of Total Estimate Gain
-16.95%

FRONT BARNETT ASSOCIATES LLC's iShares Biotechnology ETF Holding Summary

As of 2023-09-30, FRONT BARNETT ASSOCIATES LLC held 2,825.00 shares of iShares Biotechnology ETF(IBB), totaling $350,000.00. This investment constitutes 0.04% of their stock portfolio, and FRONT BARNETT ASSOCIATES LLC now holds 0% of the outstanding iShares Biotechnology ETF(IBB) stock.

The initial trade took place in 2021Q2. And since then FRONT BARNETT ASSOCIATES LLC has made 1 purchases of IBB, at an average price of $153.97, for a total of 11,327.00 shares. In addition, there have been 1 sales at an average price of $127.17 for 8,502.00 shares. Based on historical transaction data and IBB's current price of $130.00, FRONT BARNETT ASSOCIATES LLC's estimated gain on his IBB holdings is $-295,568.85, reflecting a -16.95% gain to date.

FRONT BARNETT ASSOCIATES LLC IBB ($130.00) Holding Chart

FRONT BARNETT ASSOCIATES LLC IBB ($130.00) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1